Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007
Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Treatment failure of severe and ventilator-associated pneumonia Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012
Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009
Late-onset ventilator-associated pneumonia in patients with acute nervous system infections Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005
Adrenal insufficiency and relative eosinophilia in critically ill patients with septic shock due to ventilator-associated pneumonia (VAP) Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011
Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome Source: Eur Respir J 2005; 26: Suppl. 49, 188s Year: 2005
The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 232s Year: 2004
Detection of liver function in patients with severe community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002
Community-acquired pneumonia: treatment failure and complications Source: ERS Course 2018 - Respiratory Infections Year: 2018
Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005
Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020 Year: 2020
Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017